检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:于长华[1] 朱振亚[1] 韩济华[1] 朱卫国[1] 潘鹏[1] 李涛[1]
机构地区:[1]江苏省淮安市第一人民医院(南京医科大学附属淮安医院)肿瘤放疗科,江苏淮安223300
出 处:《现代肿瘤医学》2010年第3期501-503,共3页Journal of Modern Oncology
基 金:江苏省淮安市科技支撑项目(HAS08005)
摘 要:目的:探讨食管癌根治术后纵隔转移灶同时加量调强放疗的意义和效果。方法:39例食管癌根治术后发生纵隔转移患者,设定原发灶和预防照射区进行SIB-IMRT(simultaneous integratedboost intensity-mod-ulated radiation therapy)计划设计。定义2个靶区:PTV1为需要加量照射的淋巴结靶区,给予69Gy(2.3×30次);PTV2为预防照射区,给予54Gy(1.8×30次)的剂量,设计等角度5野调强计划。结果:5野调强获得了满意的剂量分布,患者可在6周内完成治疗计划,所有患者完成了放疗,治疗后3个月复查CT,病灶达CR(complete response)占66.7%(36/54),PR(partial response)占33.3%(18/54),总有效率(CR+PR)达到100.0%。结论:食管癌根治术后纵隔转移患者进行同时加量调强放射治疗物理学优势明显,可以明显提高局部控制率,急性放射治疗反应可耐受,具有良好的应用前景。Objective :To investigate the clinical efficacy and significance of simultaneous integrated boost intensity -modulated radiotherapy (SIB -IMRT) for the patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Methods: SIB - IMRT plans were designed for 39 patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Two target volumes were predefined: PTV1, the target volume of the lymph node region,which was given to 69Gy(2.3Gy fractions), and PTV2, the target volume of elec- tively treated region ,which was given to 54Gy( 1.8Gy fractions). Five equispaced coplanar beams were applied. Re- suits:The plan with 5 intensity - modulated beams could produce good dose distribution for the two target volumes. All the patients completed the treatments in 6 weeks. The outcome was evaluated 3 months after SIB - IMRT. Patients had CR in 66.7% (36/54) ;PR 33.3% (18/54). The overall response rate was 100.0%. Conclusion: SIB - IMRT can reach a higher value of some radiation physical parameters for the patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Local - regional control rate was improved by using SIB - IMRT. The acute radiation toxicity of SIB - IMRT was well tolerated. SIB - IMRT is a promising radiotherapy modality for the advanced esophageal carcinoma.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.147.46.129